Author: Wu Yanhua Qiao Xiaojing Qiao Shouyi Yu Long
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.15, Iss.4, 2011-04, pp. : 421-437
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting Signalling Pathways in Hepatocellular Carcinoma
Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. :
Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. :
Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma
Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. :
Drugs targeting integrins for cancer therapy
By Binder Mascha Trepel Martin
Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. :